218 related articles for article (PubMed ID: 31015254)
21. PRDM14 controls X-chromosomal and global epigenetic reprogramming of H3K27me3 in migrating mouse primordial germ cells.
Mallol A; Guirola M; Payer B
Epigenetics Chromatin; 2019 Jun; 12(1):38. PubMed ID: 31221220
[TBL] [Abstract][Full Text] [Related]
22. Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia.
Jakobczyk H; Debaize L; Soubise B; Avner S; Rouger-Gaudichon J; Commet S; Jiang Y; Sérandour AA; Rio AG; Carroll JS; Wichmann C; Lie-A-Ling M; Lacaud G; Corcos L; Salbert G; Galibert MD; Gandemer V; Troadec MB
J Hematol Oncol; 2021 Mar; 14(1):47. PubMed ID: 33743795
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation.
Zhang J; Wang J; Liu Y; Sidik H; Young KH; Lodish HF; Fleming MD
Blood; 2009 Feb; 113(6):1304-14. PubMed ID: 19066392
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice.
Shing DC; Trubia M; Marchesi F; Radaelli E; Belloni E; Tapinassi C; Scanziani E; Mecucci C; Crescenzi B; Lahortiga I; Odero MD; Zardo G; Gruszka A; Minucci S; Di Fiore PP; Pelicci PG
J Clin Invest; 2007 Dec; 117(12):3696-707. PubMed ID: 18037989
[TBL] [Abstract][Full Text] [Related]
25. Mouse acute leukemia develops independent of self-renewal and differentiation potentials in hematopoietic stem and progenitor cells.
Dong F; Bai H; Wang X; Zhang S; Wang Z; Xie M; Zhang S; Wang J; Hao S; Cheng T; Ema H
Blood Adv; 2019 Feb; 3(3):419-431. PubMed ID: 30733302
[TBL] [Abstract][Full Text] [Related]
26. Transcription factor Zbtb1 interacts with bridging factor Lmo2 and maintains the T-lineage differentiation capacity of lymphoid progenitor cells.
Koizumi M; Kama Y; Hirano KI; Endo Y; Tanaka T; Hozumi K; Hosokawa H
J Biol Chem; 2022 Nov; 298(11):102506. PubMed ID: 36126774
[TBL] [Abstract][Full Text] [Related]
27. Prdm14 promotes germline fate and naive pluripotency by repressing FGF signalling and DNA methylation.
Grabole N; Tischler J; Hackett JA; Kim S; Tang F; Leitch HG; Magnúsdóttir E; Surani MA
EMBO Rep; 2013 Jul; 14(7):629-37. PubMed ID: 23670199
[TBL] [Abstract][Full Text] [Related]
28. AMKL chimeric transcription factors are potent inducers of leukemia.
Dang J; Nance S; Ma J; Cheng J; Walsh MP; Vogel P; Easton J; Song G; Rusch M; Gedman AL; Koss C; Downing JR; Gruber TA
Leukemia; 2017 Oct; 31(10):2228-2234. PubMed ID: 28174417
[TBL] [Abstract][Full Text] [Related]
29. Targeted DamID reveals differential binding of mammalian pluripotency factors.
Cheetham SW; Gruhn WH; van den Ameele J; Krautz R; Southall TD; Kobayashi T; Surani MA; Brand AH
Development; 2018 Oct; 145(20):. PubMed ID: 30185410
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of PRDM14 expression in pancreatic cancer suppresses cancer stem-like properties and liver metastasis in mice.
Moriya C; Taniguchi H; Miyata K; Nishiyama N; Kataoka K; Imai K
Carcinogenesis; 2017 Jun; 38(6):638-648. PubMed ID: 28498896
[TBL] [Abstract][Full Text] [Related]
31. PRDM14 Is a Unique Epigenetic Regulator Stabilizing Transcriptional Networks for Pluripotency.
Seki Y
Front Cell Dev Biol; 2018; 6():12. PubMed ID: 29487849
[TBL] [Abstract][Full Text] [Related]
32. PRDM14, a Zinc Finger Protein, Regulates Cancer Stemness.
Taniguchi H; Imai K
Methods Mol Biol; 2018; 1867():3-13. PubMed ID: 30155811
[TBL] [Abstract][Full Text] [Related]
33. The molecular basis of Lmo2-induced T-cell acute lymphoblastic leukemia.
Curtis DJ; McCormack MP
Clin Cancer Res; 2010 Dec; 16(23):5618-23. PubMed ID: 20861166
[TBL] [Abstract][Full Text] [Related]
34. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.
Armstrong SA; Staunton JE; Silverman LB; Pieters R; den Boer ML; Minden MD; Sallan SE; Lander ES; Golub TR; Korsmeyer SJ
Nat Genet; 2002 Jan; 30(1):41-7. PubMed ID: 11731795
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic siRNA targeting the cancer cell stemness regulator PRDI-BF1 and RIZ domain zinc finger protein 14.
Imai K; Taniguchi H
Proc Jpn Acad Ser B Phys Biol Sci; 2022; 98(7):325-335. PubMed ID: 35908955
[TBL] [Abstract][Full Text] [Related]
36. Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis.
Pronier E; Bowman RL; Ahn J; Glass J; Kandoth C; Merlinsky TR; Whitfield JT; Durham BH; Gruet A; Hanasoge Somasundara AV; Rampal R; Melnick A; Koche RP; Taylor BS; Levine RL
Blood; 2018 Sep; 132(12):1265-1278. PubMed ID: 30064973
[TBL] [Abstract][Full Text] [Related]
37. Germline development in rat revealed by visualization and deletion of
Kobayashi T; Kobayashi H; Goto T; Takashima T; Oikawa M; Ikeda H; Terada R; Yoshida F; Sanbo M; Nakauchi H; Kurimoto K; Hirabayashi M
Development; 2020 Feb; 147(4):. PubMed ID: 32001439
[TBL] [Abstract][Full Text] [Related]
38. Sequence-specific regulator Prdm14 safeguards mouse ESCs from entering extraembryonic endoderm fates.
Ma Z; Swigut T; Valouev A; Rada-Iglesias A; Wysocka J
Nat Struct Mol Biol; 2011 Feb; 18(2):120-7. PubMed ID: 21183938
[TBL] [Abstract][Full Text] [Related]
39. The PRDM14-CtBP1/2-PRC2 complex regulates transcriptional repression during the transition from primed to naïve pluripotency.
Yamamoto M; Suwa Y; Sugiyama K; Okashita N; Kawaguchi M; Tani N; Matsubara K; Nakamura A; Seki Y
J Cell Sci; 2020 Aug; 133(15):. PubMed ID: 32661086
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of the shortest isoform of histone demethylase LSD1 primes hematopoietic stem cells for malignant transformation.
Wada T; Koyama D; Kikuchi J; Honda H; Furukawa Y
Blood; 2015 Jun; 125(24):3731-46. PubMed ID: 25904247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
